Extinguishing the rewarding value of smoke cues: pharmacological and behavioral treatments
- PMID:15203786
- DOI: 10.1080/14622200410001696501
Extinguishing the rewarding value of smoke cues: pharmacological and behavioral treatments
Abstract
The present study examined several pharmacological and behavioral treatments designed to promote extinction of the responses to rewarding cigarette smoke cues. Pharmacological treatments comprised nicotine skin patches (21 mg/24 hr) and the nicotinic acetylcholine receptor antagonist mecamylamine (10 mg/day), administered separately or in combination. Behavioral manipulations included switching to denicotinized cigarettes, to cigarettes having different menthol flavor, or to ventilated-filter (low tar and nicotine) cigarettes. Smokers were assigned to the various treatments for 2 weeks before they quit smoking. During weekly test sessions, subjects rated the rewarding effects of their usual brands of cigarettes or cigarettes with different menthol content (mentholated vs. nonmentholated). Over the 2-week treatment period, all pharmacological treatments reduced ratings of reward for the usual-brand test cigarettes. Switching to smoking denicotinized cigarettes for 2 weeks similarly decreased rewarding effects of the usual-brand test cigarettes. Subjects also strongly preferred cigarettes with the same menthol content to which they were accustomed. However, manipulating the menthol content of the cigarettes smoked during the 2 weeks of treatment had different effects, depending on whether smokers habitually smoked mentholated or nonmentholated cigarettes. For menthol smokers, removal of the menthol cue hampered extinction of reward ratings for the usual-brand (mentholated) test cigarette. For nonmenthol smokers, addition of the menthol cue did not affect the progress of extinction of nonmenthol smoke cues. These findings demonstrate the importance of sensory cues in determining subjective reward and show that the reward value of these cues can be altered by removal of nicotine from tobacco or by pharmacological manipulations that interfere with the reinforcing effects of nicotine.
Similar articles
- Precessation treatment with nicotine skin patch facilitates smoking cessation.Rose JE, Behm FM, Westman EC, Kukovich P.Rose JE, et al.Nicotine Tob Res. 2006 Feb;8(1):89-101. doi: 10.1080/14622200500431866.Nicotine Tob Res. 2006.PMID:16497603Clinical Trial.
- Treating smokers before the quit date: can nicotine patches and denicotinized cigarettes reduce cravings?Rezaishiraz H, Hyland A, Mahoney MC, O'Connor RJ, Cummings KM.Rezaishiraz H, et al.Nicotine Tob Res. 2007 Nov;9(11):1139-46. doi: 10.1080/14622200701684172.Nicotine Tob Res. 2007.PMID:17978987Clinical Trial.
- Platelet monoamine oxidase, smoking cessation, and tobacco withdrawal symptoms.Rose JE, Behm FM, Ramsey C, Ritchie JC Jr.Rose JE, et al.Nicotine Tob Res. 2001 Nov;3(4):383-90. doi: 10.1080/14622200110087277.Nicotine Tob Res. 2001.PMID:11694206Clinical Trial.
- Role of nicotine pharmacokinetics in nicotine addiction and nicotine replacement therapy: a review.Le Houezec J.Le Houezec J.Int J Tuberc Lung Dis. 2003 Sep;7(9):811-9.Int J Tuberc Lung Dis. 2003.PMID:12971663Review.
- The relevance and treatment of cue-induced cravings in tobacco dependence.Ferguson SG, Shiffman S.Ferguson SG, et al.J Subst Abuse Treat. 2009 Apr;36(3):235-43. doi: 10.1016/j.jsat.2008.06.005. Epub 2008 Aug 20.J Subst Abuse Treat. 2009.PMID:18715743Review.
Cited by
- Effects of smoking on the acoustic startle response and prepulse inhibition in smokers with and without posttraumatic stress disorder.Vrana SR, Calhoun PS, McClernon FJ, Dennis MF, Lee ST, Beckham JC.Vrana SR, et al.Psychopharmacology (Berl). 2013 Dec;230(3):477-85. doi: 10.1007/s00213-013-3181-y. Epub 2013 Jul 5.Psychopharmacology (Berl). 2013.PMID:23828156Free PMC article.
- Acoustic startle and prepulse inhibition predict smoking lapse in posttraumatic stress disorder.Vrana SR, Calhoun PS, Dennis MF, Kirby AC, Beckham JC.Vrana SR, et al.J Psychopharmacol. 2015 Oct;29(10):1070-6. doi: 10.1177/0269881115598319. Epub 2015 Aug 7.J Psychopharmacol. 2015.PMID:26253620Free PMC article.
- Associations between compliance with very low nicotine content (VLNC) cigarettes, abstinence self-efficacy, and quit outcomes in a pilot smoking cessation trial.Giummo R, Oliver JA, McClernon FJ, Sweitzer MM.Giummo R, et al.Drug Alcohol Depend. 2024 Sep 1;262:111393. doi: 10.1016/j.drugalcdep.2024.111393. Epub 2024 Jul 14.Drug Alcohol Depend. 2024.PMID:39024797
- Potential therapeutic uses of mecamylamine and its stereoisomers.Nickell JR, Grinevich VP, Siripurapu KB, Smith AM, Dwoskin LP.Nickell JR, et al.Pharmacol Biochem Behav. 2013 Jul;108:28-43. doi: 10.1016/j.pbb.2013.04.005. Epub 2013 Apr 18.Pharmacol Biochem Behav. 2013.PMID:23603417Free PMC article.Review.
- The effect of nicotine and trauma context on acoustic startle in smokers with and without posttraumatic stress disorder.Calhoun PS, Wagner HR, McClernon FJ, Lee S, Dennis MF, Vrana SR, Clancy CP, Collie CF, Johnson YC, Beckham JC.Calhoun PS, et al.Psychopharmacology (Berl). 2011 May;215(2):379-89. doi: 10.1007/s00213-010-2144-9. Epub 2010 Dec 29.Psychopharmacology (Berl). 2011.PMID:21188354Free PMC article.
Publication types
MeSH terms
Substances
Related information
Grants and funding
LinkOut - more resources
Full Text Sources
Medical